Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The CooperCOO +2.90%89 Owner Earnings per Share (TTM) is 2.45 as of Apr. 2026, which is 95% below its 10-year median of 44.59. GuruFocus rates COO with a GF Score™ of 89/100 and a GF Value™ of $101.22 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 311 Medical Devices & Instruments companies, The Cooper ranks worse than 56.59% on this metric.
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
The Cooper's Owner Earnings per Share (TTM) ended in Apr. 2026 was $2.45. It's Price-to-Owner-Earnings ratio for today is 29.65.
The historical rank and industry rank for The Cooper's Owner Earnings per Share (TTM) or its related term are showing as below:
COO'
s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 17.5 Med: 44.59 Max: 294.54
Current: 29.58
During the past 13 years, the highestPrice-to-Owner-Earnings ratio of The Cooper was 294.54. The lowest was 17.50. And the median was 44.59.
COO's Price-to-Owner-Earnings is ranked worse than 56.59% of 311
companies
in the Medical Devices & Instruments industry
Industry Median: 25.08
vs COO: 29.58
Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.
Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.
The Cooper Owner Earnings per Share (TTM) Related Terms
The Cooper Owner Earnings per Share (TTM) Historical Data
* Premium members only.
The historical data trend for The Cooper's Owner Earnings per Share (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COO vs SOLV, ALGN, BAX: Owner Earnings per Share (TTM) Comparison
For the Medical Instruments & Supplies subindustry, The Cooper's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper Price-to-Owner-Earnings vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where The Cooper's Price-to-Owner-Earnings falls into.
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income.
The Cooper's Change In Deferred Tax for the trailing twelve months (TTM) ended in Apr. 2026 was $144 Mil.
4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $298 Mil
It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.
The following shows how to get maintenance capital expenditure.
First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.
The Cooper's 5-Year Average Maintenance Capital Expenditure = $298 Mil
5. "Change In Working Capital" is from cashflow statement. The Cooper's Change In Working Capital for the trailing twelve months (TTM) ended in Apr. 2026 was $12 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Owner Earnings per Share (TTM) of 2.45 mean?
The Cooper (COO) has a Owner Earnings per Share (TTM) of 2.45 as of Apr. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on The Cooper. This is 95% below median its historical median of 44.59. Over the past decade, The Cooper's Owner Earnings per Share (TTM) has ranged from 17.50 to 294.54. According to the industry distribution chart, The Cooper ranks #176 out of 311 companies in the Medical Devices & Instruments industry, placing it in the top 56.6%.
Is The Cooper's Owner Earnings per Share (TTM) too high?
The Cooper's current Owner Earnings per Share (TTM) of 2.45 is 95% below median its 10-year median of 44.59. Over the past 10 years, this metric has ranged from a low of 17.50 to a high of 294.54. The Medical Devices & Instruments industry median Owner Earnings per Share (TTM) is 25.08. The Cooper's value of 2.45 is 90.2% below this industry median. Based on the distribution chart, The Cooper ranks #176 out of 311 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, The Cooper has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Owner Earnings per Share (TTM) compare to SOLV and ALGN?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #176 out of 311 companies for Owner Earnings per Share (TTM). This places The Cooper in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 25.08. The Cooper's value of 2.45 is 90.2% below this benchmark. Historically, The Cooper's own Owner Earnings per Share (TTM) has ranged from 17.50 to 294.54 over the past decade. While the company's 10-year median is 44.59 vs. the industry median of 25.08, The Cooper has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Devices & Instruments company?
The median Owner Earnings per Share (TTM) among Medical Devices & Instruments companies is 25.08, based on 311 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current Owner Earnings per Share (TTM) of 2.45 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on The Cooper. For the Medical Devices & Instruments industry, the median Owner Earnings per Share (TTM) is 25.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current Owner Earnings per Share (TTM) is 2.45, which is 95% below median its own 10-year median of 44.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Modestly Undervalued. The stock's GF Value™ is $101.22, compared to a current price of $72.65 — trading 28.2% below its estimated fair value. The current Owner Earnings per Share (TTM) is 2.45, which is 95% below median its 10-year median of 44.59 and 90.2% below the Medical Devices & Instruments industry median of 25.08. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For The Cooper (COO), the current Owner Earnings per Share (TTM) is 2.45 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $72.65 is trading 28.2% below its estimated GF Value™ of $101.22.
GuruFocus considers The Cooper to be Modestly Undervalued.
Key valuation signals for COO:
Owner Earnings per Share (TTM): 2.45 (95% below median its 10-year median of 44.59)
GF Value™: $101.22 vs. price of $72.65 (28.2% below fair value)
Industry Position: 90.2% below the Medical Devices & Instruments median (#176 of 311)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score
Get the complete analysis for COO
Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
